secwatch.observer — SEC 8-K summary
======================================

Issuer:     Novo Integrated Sciences, Inc. (—)
CIK:        0001138978
Form:       8-K
Filed at:   2025-03-11T23:59:59+00:00
Accession:  0001493152-25-009859
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Novo Integrated Sciences extends CEO resignation to March 31, 2025; Mattacchione to stay as Chairman
--------------------------------------------------------------------------------

- CEO Robert Mattacchione's resignation, previously set for February 5, 2025 and extended twice, now extended to no later than March 31, 2025.
- After stepping down as CEO, Mattacchione will remain Chairman of the Board and Chairman of subsidiary Novo Healthnet Limited.
- Resignation is not due to any disagreement with company operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138978/000149315225009859/0001493152-25-009859-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138978/000149315225009859/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009859

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer